Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Accuray Inc ARAY

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.


NDAQ:ARAY - Post by User

Bullboard Posts
Post by skyhighon Sep 25, 2007 1:38am
119 Views
Post# 13461074

CEO to speak at UBS Global Sciences Conferenc

CEO to speak at UBS Global Sciences ConferencAccuray Incorporated's CEO to Speak at UBS Global Life Sciences Conference Ticker Symbol: U:ARAY SUNNYVALE, Calif., Sept. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated , a global leader in the field of radiosurgery, announced today that its president and CEO, Euan S. Thomson, Ph.D., is scheduled to present a corporate update at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York City, on Tuesday, September 25, 2007 at 1:30 p.m. EDT. A live webcast of the presentation will be available online from the investor relations page of the Company's corporate website at https://www.accuray.com. The webcast replay of the presentation will begin three hours after the conclusion of the live presentation and will be available until October 27, 2007. About Accuray Accuray Incorporated , based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 35,000 patients worldwide and currently more than 100 systems. Accuray Incorporated CONTACT: investors, Tom Rathjen, Vice President, Investor Relations, +1-408-789-4458, trathjen@accuray.com, or media, Stephanie Tomei, Public Relations Manager, +1-408-789-4234, stomei@accuray.com, both of Accuray Incorporated Web site: https://www.accuray.com/
Bullboard Posts